CPG
ZYME icon

Cornerstone Planning Group’s Zymeworks ZYME Stock Holding History

Cornerstone Planning Group’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-35
Closed -$439 – 1775
2025
Q2 		$439 Buy
+35
New +$417 ﹤0.01% 1337
2025
Q1 		– Sell
-161
Closed -$2.33K – 1701
2024
Q4 		$2.33K Hold
161
– – ﹤0.01% 753
2024
Q3 		$2.21K Buy
+161
New +$1.75K ﹤0.01% 750

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Cornerstone Planning Group's ZYME Position: Q3 2025 in Review

Cornerstone Planning Group sold out of Zymeworks (ZYME) in Q3 2025, closing a stake of 35 shares — an estimated $439 sold.

Cornerstone Planning Group first reported a position in ZYME in Q3 2024 and held it in 3 quarters. The position peaked at $2.33K in Q4 2024. 183 funds tracked by Wall St. Rank hold ZYME as of Q3 2025.

  • Cornerstone Planning Group reported no remaining Zymeworks position as of Q3 2025 after selling out during the quarter.
  • Cornerstone Planning Group sold 35 Zymeworks shares in Q3 2025, an estimated $439.
  • Cornerstone Planning Group first reported a position in Zymeworks in Q3 2024 and held it in 3 quarters.
  • Cornerstone Planning Group's Zymeworks position peaked at $2.33K in Q4 2024.
  • 183 funds tracked by Wall St. Rank held Zymeworks as of Q3 2025.

Based on Cornerstone Planning Group's 13F filing for Q3 2025, filed 4 Nov 2025.